Sign Up to like & get
recommendations!
1
Published in 2022 at "RSC Advances"
DOI: 10.1039/d2ra01968j
Abstract: CDK2 inhibition is an appealing target for cancer treatment that targets tumor cells in a selective manner. A new set of small molecules featuring the privileged pyrazolo[3,4-d]pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffolds (4–13) as well as the…
read more here.
Keywords:
triazolo pyrimidine;
pyrazolo triazolo;
pyrazolo pyrimidine;
activity ... See more keywords